We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Impact of co-morbidities in COVID-19 infected patients.
- Authors
Verma, Preeti; Chaudhary, Sachin; Kaur, Samarjeet; Midha, Tanu; Martolia, Dinesh Singh
- Abstract
Background-During the COVID-19 pandemic in the first wave, infected patients age was range from 4 weeks to 90 years and those who have more age and with comorbidities are more susceptible to develop serious illness and have high mortality rates. Objective-To study the association between survivor vs non survivor on the basis of demographic profile and high risk factors. Material & methods: This study was done in the Government Medical College, Kannauj on the COVID-19 patients who were admitted in the isolation wards, from 1st September 2020 to December 31st 2020. Statistical Analysis- Analysis was done using SPSS- 23 trial version software. Results: case fatality rate was 2.7% in this study. Most common symptoms was cough (61.0%) and among these admitted patients the most common comorbidities was hypertension (26.7%), followed by diabetes (20.7%), and COPD (14.0%) respectively. Platelets (< 0.02), post prandial blood sugar (PPBS) (< 0.01) have significant role in survivability of COVID- 19 patients. Conclusion: This study concludes that those patients who were older in age and with comorbidity especially (hypertension, COPD, high PPBS, High platelets) have poorer prognosis as compare to those without.
- Subjects
INDIA; HYPERTENSION; COVID-19; AGE distribution; DIABETES; BLOOD sugar; RISK assessment; TREATMENT effectiveness; OBSTRUCTIVE lung diseases; PLATELET count; DISEASE complications; COMORBIDITY; COVID-19 pandemic
- Publication
Indian Journal of Community Health, 2022, Vol 34, Issue 1, p26
- ISSN
0971-7587
- Publication type
Article
- DOI
10.47203/IJCH.2022.v34i01.006